BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36893514)

  • 1. Treatment adherence in a smoking cessation clinical trial for individuals with current or past major depressive disorder: Predictors and association with cessation.
    Schnoll R; Barrila GM; Dalsimer S; Hosie Quinn M; Bauer AM; Fox E; Olonoff M; Jao NC; Leone F; Huffman MD; Khan SS; Gollan JK; Papandonatos GD; Hitsman B
    Addict Behav; 2023 Aug; 143():107686. PubMed ID: 36893514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History and Correlates of Smoking Cessation Behaviors Among Individuals With Current or Past Major Depressive Disorder Enrolled in a Smoking Cessation Trial.
    Quinn MH; Olonoff M; Bauer AM; Fox E; Jao N; Lubitz SF; Leone F; Gollan JK; Schnoll R; Hitsman B
    Nicotine Tob Res; 2022 Jan; 24(1):37-43. PubMed ID: 34259871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between changes in alternative reinforcers and short-term smoking cessation.
    Goelz PM; Audrain-McGovern JE; Hitsman B; Leone FT; Veluz-Wilkins A; Jepson C; Wileyto EP; D'Avanzo PA; Rivera JG; Schnoll RA
    Drug Alcohol Depend; 2014 May; 138():67-74. PubMed ID: 24598122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of adherence to nicotine replacement therapy: Machine learning evidence that perceived need predicts medication use.
    Kim N; McCarthy DE; Loh WY; Cook JW; Piper ME; Schlam TR; Baker TB
    Drug Alcohol Depend; 2019 Dec; 205():107668. PubMed ID: 31707266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes.
    Schnoll RA; Hitsman B; Blazekovic S; Veluz-Wilkins A; Wileyto EP; Leone FT; Audrain-McGovern JE
    Drug Alcohol Depend; 2016 Aug; 165():245-52. PubMed ID: 27372219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit?
    Schlam TR; Cook JW; Baker TB; Hayes-Birchler T; Bolt DM; Smith SS; Fiore MC; Piper ME
    Psychopharmacology (Berl); 2018 Jul; 235(7):2065-2075. PubMed ID: 29696311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of medication adherence and smoking cessation among smokers under community corrections supervision.
    Cropsey KL; Clark CB; Stevens EN; Schiavon S; Lahti AC; Hendricks PS
    Addict Behav; 2017 Feb; 65():111-117. PubMed ID: 27816035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression Severity Moderates Reward Learning Among Smokers With Current or Past Major Depressive Disorder in a Smoking Cessation Randomized Clinical Trial.
    Gollan JK; Liverant G; Jao NC; Lord KA; Whitton AE; Hogarth L; Fox E; Bauer AM; Quinn MH; Pizzagalli DA; Leone FT; Papandonatos GD; Schnoll RA; Hitsman B
    Nicotine Tob Res; 2024 Apr; 26(5):639-644. PubMed ID: 37943674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Varenicline Adherence Among Cancer Patients Treated for Tobacco Dependence and its Association With Smoking Cessation.
    Crawford G; Weisbrot J; Bastian J; Flitter A; Jao NC; Carroll A; Kalhan R; Leone F; Hitsman B; Schnoll R
    Nicotine Tob Res; 2019 Jul; 21(8):1135-1139. PubMed ID: 29955828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of adherence to pharmacological and behavioral treatment in a cessation trial among smokers in Aleppo, Syria.
    Ben Taleb Z; Ward KD; Asfar T; Bahelah R; Maziak W
    Drug Alcohol Depend; 2015 Aug; 153():167-72. PubMed ID: 26077603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Adherence to Transdermal Nicotine Patches within a Smoking Cessation Effectiveness Trial.
    Handschin J; Hitsman B; Blazekovic S; Veluz-Wilkins A; Wileyto EP; Leone FT; Schnoll RA
    J Smok Cessat; 2018 Mar; 13(1):33-43. PubMed ID: 31223345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-related disease factors and smoking cessation treatment: Analysis of an ongoing clinical trial.
    Carroll AJ; Veluz-Wilkins AK; Blazekovic S; Kalhan R; Leone FT; Wileyto EP; Schnoll RA; Hitsman B
    Psychooncology; 2018 Feb; 27(2):471-476. PubMed ID: 28636795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evidence that adherence to counseling mediates the effects of pretreatment self-efficacy and motivation on outcome of a cessation attempt in smokers with ADHD.
    Heffner JL; Lewis DF; Winhusen TM
    Nicotine Tob Res; 2013 Feb; 15(2):393-400. PubMed ID: 22949577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial.
    Hitsman B; Papandonatos GD; Gollan JK; Huffman MD; Niaura R; Mohr DC; Veluz-Wilkins AK; Lubitz SF; Hole A; Leone FT; Khan SS; Fox EN; Bauer AM; Wileyto EP; Bastian J; Schnoll RA
    Addiction; 2023 Sep; 118(9):1710-1725. PubMed ID: 37069490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice Smokers.
    Cropsey KL; Clark CB; Zhang X; Hendricks PS; Jardin BF; Lahti AC
    Am J Prev Med; 2015 Sep; 49(3):335-44. PubMed ID: 26091924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of evidence-based smoking cessation treatments by psychiatric inpatient smokers with depression.
    Strong DR; Uebelacker L; Fokas K; Saritelli J; Matsko S; Abrantes AM; Schonbrun Y
    J Addict Med; 2014; 8(2):77-83. PubMed ID: 24562400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quitting Failure and Success With and Without Using Medication: Latent Classes of Abstinence and Adherence to Nicotine Monotherapy, Combination Therapy, and Varenicline.
    McCarthy DE; Versella MV
    Nicotine Tob Res; 2019 Oct; 21(11):1488-1495. PubMed ID: 30107419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; McDermott MS; Lindson-Hawley N; Vogt F; Farley A; Aveyard P
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009164. PubMed ID: 25914910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.